Events Site - Investor Navigation Corporate Profile Press Releases Events & Presentations Stock Information Stock Quote & Chart Historic Price Lookup Analyst Coverage Financial Filings SEC Filings Governance Documents & Charters Committee Composition Resources Investor FAQs Investor Email Alerts Upcoming Events There are no upcoming events scheduled at this time. Past Events May 15, 2026 83rd Annual Society for Investigative Dermatology (SID) Meeting Oral Presentation: Preclinical characterization of IMG-007, a high-affinity, non-depleting anti-OX40 monoclonal antibody for the treatment of inflammatory and autoimmune disease 5.1 MB Poster Presentation: Preclinical characterization of IMG-007, a high-affinity, non-depleting anti-OX40 monoclonal antibody for the treatment of inflammatory and autoimmune disease 2.5 MB Apr 14, 2026 at 1:30 PM EDT H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference Click here for webcast Mar 10, 2026 at 3:00 PM EDT 2026 Leerink Global Healthcare Conference Click here for webcast Dec 04, 2025 at 10:00 AM EST Piper Sander 37th Annual Healthcare Conference Click here for webcast Nov 13, 2025 at 9:20 AM EST 2025 Stifel Healthcare Conference Click here for webcast Nov 12 - Nov 15, 2025 6th Annual Inflammatory Skin Disease Summit (ISDS) Presentation 1.4 MB Oral Presentation: Anti-OX40 monoclonal antibody IMG-007 exhibited clinical activity of hair regrowth, suppressed scalp inflammatory biomarkers in patients with severe alopecia areata in a Ph1b/2a study 678.4 KB Poster Presentation: IMG-007, a non-depleting anti-OX40 monoclonal antibody, reduced skin lesion severity and serum inflammatory markers in adults with moderate-to-severe atopic dermatitis in a Phase 1b/2a study 280.9 KB Presentations May 07, 2026 ImageneBio Corporate Presentation Download
Upcoming Events There are no upcoming events scheduled at this time. Past Events May 15, 2026 83rd Annual Society for Investigative Dermatology (SID) Meeting Oral Presentation: Preclinical characterization of IMG-007, a high-affinity, non-depleting anti-OX40 monoclonal antibody for the treatment of inflammatory and autoimmune disease 5.1 MB Poster Presentation: Preclinical characterization of IMG-007, a high-affinity, non-depleting anti-OX40 monoclonal antibody for the treatment of inflammatory and autoimmune disease 2.5 MB Apr 14, 2026 at 1:30 PM EDT H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference Click here for webcast Mar 10, 2026 at 3:00 PM EDT 2026 Leerink Global Healthcare Conference Click here for webcast Dec 04, 2025 at 10:00 AM EST Piper Sander 37th Annual Healthcare Conference Click here for webcast Nov 13, 2025 at 9:20 AM EST 2025 Stifel Healthcare Conference Click here for webcast Nov 12 - Nov 15, 2025 6th Annual Inflammatory Skin Disease Summit (ISDS) Presentation 1.4 MB Oral Presentation: Anti-OX40 monoclonal antibody IMG-007 exhibited clinical activity of hair regrowth, suppressed scalp inflammatory biomarkers in patients with severe alopecia areata in a Ph1b/2a study 678.4 KB Poster Presentation: IMG-007, a non-depleting anti-OX40 monoclonal antibody, reduced skin lesion severity and serum inflammatory markers in adults with moderate-to-severe atopic dermatitis in a Phase 1b/2a study 280.9 KB Presentations May 07, 2026 ImageneBio Corporate Presentation Download
May 15, 2026 83rd Annual Society for Investigative Dermatology (SID) Meeting Oral Presentation: Preclinical characterization of IMG-007, a high-affinity, non-depleting anti-OX40 monoclonal antibody for the treatment of inflammatory and autoimmune disease 5.1 MB Poster Presentation: Preclinical characterization of IMG-007, a high-affinity, non-depleting anti-OX40 monoclonal antibody for the treatment of inflammatory and autoimmune disease 2.5 MB
Oral Presentation: Preclinical characterization of IMG-007, a high-affinity, non-depleting anti-OX40 monoclonal antibody for the treatment of inflammatory and autoimmune disease 5.1 MB
Poster Presentation: Preclinical characterization of IMG-007, a high-affinity, non-depleting anti-OX40 monoclonal antibody for the treatment of inflammatory and autoimmune disease 2.5 MB
Apr 14, 2026 at 1:30 PM EDT H.C. Wainwright 4th Annual Inflammatory Skin Disease Virtual Conference Click here for webcast
Nov 12 - Nov 15, 2025 6th Annual Inflammatory Skin Disease Summit (ISDS) Presentation 1.4 MB Oral Presentation: Anti-OX40 monoclonal antibody IMG-007 exhibited clinical activity of hair regrowth, suppressed scalp inflammatory biomarkers in patients with severe alopecia areata in a Ph1b/2a study 678.4 KB Poster Presentation: IMG-007, a non-depleting anti-OX40 monoclonal antibody, reduced skin lesion severity and serum inflammatory markers in adults with moderate-to-severe atopic dermatitis in a Phase 1b/2a study 280.9 KB
Oral Presentation: Anti-OX40 monoclonal antibody IMG-007 exhibited clinical activity of hair regrowth, suppressed scalp inflammatory biomarkers in patients with severe alopecia areata in a Ph1b/2a study 678.4 KB
Poster Presentation: IMG-007, a non-depleting anti-OX40 monoclonal antibody, reduced skin lesion severity and serum inflammatory markers in adults with moderate-to-severe atopic dermatitis in a Phase 1b/2a study 280.9 KB
